ACM

Sanofi Pastr

Stock
Stock
ISIN: GB0006941792
Ticker: ACM
GB0006941792
ACM

Price

Price

CHART BY

Frequently asked questions

Sanofi Pastr's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -0.153. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Sanofi Pastr's stock, with a consensus target price of $2.375. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Sanofi Pastr reported a revenue of $31.63M.
Sanofi Pastr's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$28.69M. EBITDA measures the company's overall financial performance.
Sanofi Pastr has a free cash flow of -$18.95M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Sanofi Pastr employs approximately 206 people. It operates in the Health Care sector, specifically within the Biotechnology industry.

Financials

EPS (TTM) 
-0.153
Revenue (TTM) 
$31.63M
EBITDA (TTM) 
-$28.69M
Free Cashflow (TTM) 
-$18.95M

Analyst Ratings

The price target is $2.375 and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.

Employees
206
Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
GB0006941792
Primary Ticker
ACM

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation